TRPM3 and developmental and epileptic encephalopathy: The more surprising were two recent publications that reported de novo mutations in TRPM3 as the cause of developmental and epileptic encephalopathies (DEEs) in a total of nine patients (Dyment et al., 2019; de Sainte Agathe et al., 2020).